Paid Clinical Trials Indiana

Discover 1,123 paid clinical trials in Indiana. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,123

ImmunotherapyImmunotherapy Before and After Surgery for Treatment of Recurrent or Progressive High Grade Glioma in Children and Young Adults

Recruiting

PHASE1

Sponsor:

Sabine Mueller, MD, PhD

Location:

Indianapolis IN, Saint Louis MO, Birmingham AL, Durham NCshow 9 more

Code:

NCT04323046

Conditions

Glioblastoma

Malignant Glioma

Recurrent Glioblastoma

Recurrent Malignant Glioma

Recurrent Grade III Glioma

Eligibility Criteria

Sex: All

Age: 6 - 25

Healthy Volunteers: Not accepted

Interventions

Nivolumab

Quality-of-Life Assessment

Questionnaire Administration

Remibrutinib vs. TeriflunomideEfficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)

Recruiting

PHASE3

Sponsor:

Novartis Pharmaceuticals

Location:

Dayton OH, Merrillville IN, Nicholasville KY, Columbus OHshow 59 more

Code:

NCT05156281

Conditions

Relapsing Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Remibrutinib

Teriflunomide

DAY301To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of DAY301 in Participants With Locally Advanced or Metastatic Solid Tumors

Recruiting

PHASE1

Sponsor:

Day One Biopharmaceuticals, Inc.

Location:

Indianapolis IN, Grand Rapids MI, San Antonio TX

Code:

NCT06752681

Conditions

Advanced or Metastatic Solid Tumors

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

DAY301

BT8009Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies

Recruiting

PHASE1

PHASE2

Sponsor:

BicycleTx Limited

Location:

Lafayette IN, Louisville KY, Nashville TN, Cleveland OHshow 10 more

Code:

NCT04561362

Conditions

Urinary Bladder Neoplasm

Triple Negative Breast Neoplasms

Hormone Receptor Positive, HER2-negative Neoplasms

Hormone Receptor Positive, HER2-low Neoplasms

Breast Neoplasms

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

BT8009

Pembrolizumab

Observational StudyLGMD R1 Natural History Study

Recruiting

Sponsor:

Virginia Commonwealth University

Location:

Shipshewana IN, Columbus OH, Saint Louis MO, Iowa City IAshow 6 more

Code:

NCT05618080

Conditions

Calpain-3 Deficiency Limb Girdle Muscular Dystrophy Type 2A

Limb Girdle Muscular Dystrophy

Limb Girdle Muscular Dystrophy Type R1

LGMD2A

Eligibility Criteria

Sex: All

Age: 12 - 50

Healthy Volunteers: Not accepted

Crenolanib vs. MidostaurinStudy of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML

Recruiting

PHASE3

Sponsor:

Arog Pharmaceuticals, Inc.

Location:

Indianapolis IN, Chicago IL, Detroit MI, Iowa City IAshow 17 more

Code:

NCT03258931

Conditions

Newly Diagnosed FLT3 Mutated AML

Eligibility Criteria

Sex: All

Age: 18 - 60

Healthy Volunteers: Not accepted

Interventions

Crenolanib

Midostaurin

Cytarabine

Duanorubicin

BIIB091 & DRFA Study to Learn About the Safety of BIIB091 and Its Effect on Brain Inflammation When Taken Alone or With Diroximel Fumarate (DRF) in Adults With Relapsing Forms of Multiple Sclerosis (MS)

Recruiting

PHASE2

Sponsor:

Biogen

Location:

Cincinnati OH, Fort Wayne IN, Columbus OH, Saint Louis MOshow 19 more

Code:

NCT05798520

Conditions

Relapsing Forms of Multiple Sclerosis

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

BIIB091

DRF

Placebo

Observational StudyStudy of Systemic Amyloidosis Presentation and Prognosis

Recruiting

Sponsor:

National Center for Research Resources (NCRR)

Location:

Indianapolis IN

Code:

NCT00004374

Conditions

Amyloidosis

Eligibility Criteria

Sex: All

Age: 0 - 70+

Healthy Volunteers: Not accepted

Nivolumab & TovorafenibNivolumab and Tovorafenib for Treatment of Craniopharyngioma in Children and Young Adults

Recruiting

PHASE2

Sponsor:

Sabine Mueller, MD, PhD

Location:

Indianapolis IN, Chicago IL, Ann Arbor MI, Saint Louis MOshow 11 more

Code:

NCT05465174

Conditions

Craniopharyngioma, Child

Craniopharyngioma

Recurrent Craniopharyngioma

Eligibility Criteria

Sex: All

Age: 1 - 39

Healthy Volunteers: Not accepted

Interventions

Nivolumab

Tovorafenib

PegozaferminA Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Recruiting

PHASE3

Sponsor:

89bio, Inc.

Location:

Cincinnati OH, Dayton OH, New Albany IN, Hammond INshow 89 more

Code:

NCT06419374

Conditions

Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Pegozafermin

Placebo

Popular cities in Indiana

Indianapolis South Bend Fort Wayne Evansville